drugset / Trial / NCT00638859
Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective is to assess the safety of telithromycin (HMR3647) 20 mg/kg qd for 5-7 days in children with community-acquired pneumonia (CAP). Secondary objectives are to assess Pharmacokinetics, Efficacy and Acceptability of telithromycin 20 mg/kg qd for 5-7 days in children with CAP.
Timeline
- Start
- 2004-03
- Primary completion
- 2004-10
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telithromycin | Small molecule | 20 mg/kg | — |